Art

J-GLOBAL ID：201802228063005613   Reference number：18A2011049

Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer

原発性T1膀胱癌に対する二回目の経尿道的切除術後の膀胱内Calmette-Guerin桿菌療法

Author (12)： BABA Masato (Shiga Univ. Medical Sci., Shiga, JPN) ,  BABA Masato (Saiseikai Shigaken Hospital, Ritto, JPN) ,  KAGEYAMA Susumu (Shiga Univ. Medical Sci., Shiga, JPN) ,  YOSHIDA Tetsuya (Shiga Univ. Medical Sci., Shiga, JPN) ,  FUJIWARA Ryo (Kohka Public Hospital, Koka, JPN) ,  KIM Chul Jang (Kohka Public Hospital, Koka, JPN) ,  TAKIMOTO Keita (Saiseikai Shigaken Hospital, Ritto, JPN) ,  NAGASAWA Masayuki (Toyosato Hospital, Toyosato, JPN) ,  SOGA Hiroki (Toyosato Hospital, Toyosato, JPN) ,  NAGATANI Yukihiro (Hikone Municipal Hospital, Hikone, JPN) ,  NISHIKAWA Zenkai (Hino Memorial Hospital, Hino, JPN) ,  KAWAUCHI Akihiro (Shiga Univ. Medical Sci., Shiga, JPN)
Material： International Journal of Clinical Oncology  (Int J Clin Oncol)
Volume： 23  Issue： 5  Page： 951-956  Publication year： Oct. 2018 
JST Material Number： L3966A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： five-year relapse-free survival rate ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A2011049&from=J-GLOBAL&jstjournalNo=L3966A") }}

JST classification (2)： Immunotherapy for tumors  (GE03035B) ,  Urogenital tumors(=neoplasms)  (GM04000S)

Reference (22)：

• Clark PE, Agarwal N, Biagioli MC et al (2013) Bladder cancer. J Natl Compr Canc Netw 11:446-475
• Babjuk M, Bohle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447-461
• Sylvester RJ, van der Meijden APM, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466-477
• Hall MC, Chang SS, Dalbagni G et al (2007) Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178:2314-2330
• Divrik RT, Sahin AF, Yildirim U et al (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185-190

Terms in the title (6)： 原発 ,  膀胱癌 ,  経尿道的切除術 ,  膀胱 ,  桿菌 ,  療法